Oral Cladribine Leaves Chronic Brain Inflammation Unchecked in Multiple Sclerosis Pilot Study
A prospective pilot study reveals that oral cladribine fails to reduce diffuse TSPO-PET glial activation in normal-appearing white matter despite ...
A prospective pilot study reveals that oral cladribine fails to reduce diffuse TSPO-PET glial activation in normal-appearing white matter despite ...
A longitudinal study of nine multiple sclerosis patients reveals that rising central TSPO PET activity in newly developing lesions precedes ...
A clinical expert panel has outlined a structured multimodal framework to uncover subtle disability progression independent of relapses in people ...
Resting-state electroencephalography signatures reveal feature-specific associations with structural brain damage in multiple sclerosis, with central beta power tracking lesion burden ...
A comprehensive review assesses how magnetic susceptibility source separation integrates magnetic resonance field and relaxation measurements to isolate overlapping iron- ...
A four-year longitudinal study reveals that quantitative MRI distributions of lesion myelin integrity predict cognitive processing speed in multiple sclerosis.
A longitudinal study of early relapsing–remitting multiple sclerosis finds that paramagnetic rim lesions and enlarged choroid plexus volume at diagnosis ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.